Coriolis Pharma expands its ATMP development facilities
The cell and gene therapy formulation R&D specialist will add a BSL2 facility, totaling Coriolis Pharma’s floor space to 7,800 m2. The new...
Nanosyrinx raises £6.2m to validate drug delivery platform
The financing round was co-led by incoming Octopus Ventures and existing Dutch investor M Ventures (Amsterdam), the corporate venture capital arm of...
Meatable teams up with Royal DSM
The two Dutch companies have entered into a joint development agreement. DSM and Meatable will work on the development of meat-like taste and texture...
EU ends litigation with AstraZeneca
The Commission announced that they have reached an agreement with the British drug maker to secure the delivery of the remaining 200 COVID-19 vaccine...
British drug developer Mission Therapeutics plc earns $20m milestone
In the second major milestone of the companies’ research and preclinical development collaboration, AbbVie has nominated two deubiquitylating enzymes...
Promethera bags €20m for liver failure treatment
The Belgian cell therapy specialist was supported by an investor consortium from Belgium, Germany and China. The Hongkong company Tata Health...
NFL Biosciences goes public, raises €5m
NFL Biosciences, based in Montpellier, develops botanical drugs treating addiction. Its most advanced candidate is NFL-101. The allergenic extract...